NCT02116335View on ClinicalTrials.gov

Endothelin Receptor Function and Acute Stress

NAActive, not recruitingINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Hypertension
Interventions
DRUG

Bosentan

Stress response and vascular function will be assessed 3 days following 125 mg twice per day of Bosentan

DRUG

Placebo

Stress response and vascular function will be assessed 3 days following twice per day placebo

Trial Locations (1)

30912

Georgia Regents University, Augusta

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Augusta University

OTHER

NCT02116335 - Endothelin Receptor Function and Acute Stress | Biotech Hunter | Biotech Hunter